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Moderate hyperoxia alters alveolar and vascular lung morphogenesis. Nitric oxide 
(NO) and matrix metalloproteinases (MMP) have a crucial role in the homeostasis of 
the matrix and bronchoalveolar structure and may be regulated abnormally by expo-
sure to hyperoxia. Disruption of vascular endothelial growth factor (VEGF)-NO sign-
aling impairs vascular growth and contributes to hyperoxia-induced vascular disease 
in bronchopulmonary dysplasia (BPD). We hypothesize that L-citrulline, by raising 
the serum levels of L-arginine and enhancing endogenous NO synthesis, might atten-
uate hyperoxia-induced lung injury in an experimental model of BPD. Neonatal rats 
(1 day old) were exposed to 60% oxygen or room air for 14 days and administered 
L-citrulline or a vehicle (sham). Lung morphometry were performed; Serum was 
tested for arginine level; Matrix metalloproteinases2 (MMP2) gene expression, VEGF 
gene and protein expression and endothelial NO synthase (eNOS) protein expression 
were compared. 
Mean linear intercept was higher in the hyperoxia and sham groups when com-
pared with the room air (RA) and L-citr+hyperoxia treated group (p<0.02). Second-
ary crests number was higher in L-citrulline treated and RA when compared to 
hyperoxia and sham group (p<0.02). L-Arginine level rose in the L-citrulline-treated 
group (p<0.05). L-citrulline did not aff ect MMP2 gene expression, but it regulated the 
MMP2 active protein, which rose in bronchoalveolar lavage ﬂ uid (p<0.05), presum-
ably due to a post-transductional eff ect. 
Compared with RA controls, hyperoxia signifi cantly decreased VEGF and eNOS 
protein expression. At the same time, an increased lung VEGF gene and protein 
expression (p<0.05) were also seen in the rats treated with L-citrulline. We conclude 
that: (i) hyperoxia decreases growth and disrupts VEGF-NO signaling of lung; (ii) the 
main eff ects of L-citrulline are an increased serum level of arginine, as a promoter 
and a substrate of the nitric oxide synthase; and (ii) a better alveolar growth and 
matrix control than in hyperoxia-induced lung damage seems promising. 
